Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.

Identifieur interne : 001352 ( PubMed/Curation ); précédent : 001351; suivant : 001353

Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.

Auteurs : Min Ke [République populaire de Chine] ; Yu Chen ; Andong Wu ; Ying Sun ; Ceyang Su ; Hao Wu ; Xu Jin ; Jiali Tao ; Yi Wang ; Xiao Ma ; Ji-An Pan ; Deyin Guo

Source :

RBID : pubmed:22659295

Descripteurs français

English descriptors

Abstract

Coronaviruses are the etiological agents of respiratory and enteric diseases in humans and livestock, exemplified by the life-threatening severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV). However, effective means for combating coronaviruses are still lacking. The interaction between nonstructural protein (nsp) 10 and nsp16 has been demonstrated and the crystal structure of SARS-CoV nsp16/10 complex has been revealed. As nsp10 acts as an essential trigger to activate the 2'-O-methyltransferase activity of nsp16, short peptides derived from nsp10 may have inhibitory effect on viral 2'-O-methyltransferase activity. In this study, we revealed that the domain of aa 65-107 of nsp10 was sufficient for its interaction with nsp16 and the region of aa 42-120 in nsp10, which is larger than the interaction domain, was needed for stimulating the nsp16 2'-O-methyltransferase activity. We further showed that two short peptides derived from the interaction domain of nsp10 could inhibit the 2'-O-methyltransferase activity of SARS-CoV nsp16/10 complex, thus providing a novel strategy and proof-of-principle study for developing peptide inhibitors against SARS-CoV.

DOI: 10.1016/j.virusres.2012.05.017
PubMed: 22659295

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22659295

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.</title>
<author>
<name sortKey="Ke, Min" sort="Ke, Min" uniqKey="Ke M" first="Min" last="Ke">Min Ke</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Chen, Yu" sort="Chen, Yu" uniqKey="Chen Y" first="Yu" last="Chen">Yu Chen</name>
</author>
<author>
<name sortKey="Wu, Andong" sort="Wu, Andong" uniqKey="Wu A" first="Andong" last="Wu">Andong Wu</name>
</author>
<author>
<name sortKey="Sun, Ying" sort="Sun, Ying" uniqKey="Sun Y" first="Ying" last="Sun">Ying Sun</name>
</author>
<author>
<name sortKey="Su, Ceyang" sort="Su, Ceyang" uniqKey="Su C" first="Ceyang" last="Su">Ceyang Su</name>
</author>
<author>
<name sortKey="Wu, Hao" sort="Wu, Hao" uniqKey="Wu H" first="Hao" last="Wu">Hao Wu</name>
</author>
<author>
<name sortKey="Jin, Xu" sort="Jin, Xu" uniqKey="Jin X" first="Xu" last="Jin">Xu Jin</name>
</author>
<author>
<name sortKey="Tao, Jiali" sort="Tao, Jiali" uniqKey="Tao J" first="Jiali" last="Tao">Jiali Tao</name>
</author>
<author>
<name sortKey="Wang, Yi" sort="Wang, Yi" uniqKey="Wang Y" first="Yi" last="Wang">Yi Wang</name>
</author>
<author>
<name sortKey="Ma, Xiao" sort="Ma, Xiao" uniqKey="Ma X" first="Xiao" last="Ma">Xiao Ma</name>
</author>
<author>
<name sortKey="Pan, Ji An" sort="Pan, Ji An" uniqKey="Pan J" first="Ji-An" last="Pan">Ji-An Pan</name>
</author>
<author>
<name sortKey="Guo, Deyin" sort="Guo, Deyin" uniqKey="Guo D" first="Deyin" last="Guo">Deyin Guo</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22659295</idno>
<idno type="pmid">22659295</idno>
<idno type="doi">10.1016/j.virusres.2012.05.017</idno>
<idno type="wicri:Area/PubMed/Corpus">001352</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001352</idno>
<idno type="wicri:Area/PubMed/Curation">001352</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001352</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.</title>
<author>
<name sortKey="Ke, Min" sort="Ke, Min" uniqKey="Ke M" first="Min" last="Ke">Min Ke</name>
<affiliation wicri:level="1">
<nlm:affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Chen, Yu" sort="Chen, Yu" uniqKey="Chen Y" first="Yu" last="Chen">Yu Chen</name>
</author>
<author>
<name sortKey="Wu, Andong" sort="Wu, Andong" uniqKey="Wu A" first="Andong" last="Wu">Andong Wu</name>
</author>
<author>
<name sortKey="Sun, Ying" sort="Sun, Ying" uniqKey="Sun Y" first="Ying" last="Sun">Ying Sun</name>
</author>
<author>
<name sortKey="Su, Ceyang" sort="Su, Ceyang" uniqKey="Su C" first="Ceyang" last="Su">Ceyang Su</name>
</author>
<author>
<name sortKey="Wu, Hao" sort="Wu, Hao" uniqKey="Wu H" first="Hao" last="Wu">Hao Wu</name>
</author>
<author>
<name sortKey="Jin, Xu" sort="Jin, Xu" uniqKey="Jin X" first="Xu" last="Jin">Xu Jin</name>
</author>
<author>
<name sortKey="Tao, Jiali" sort="Tao, Jiali" uniqKey="Tao J" first="Jiali" last="Tao">Jiali Tao</name>
</author>
<author>
<name sortKey="Wang, Yi" sort="Wang, Yi" uniqKey="Wang Y" first="Yi" last="Wang">Yi Wang</name>
</author>
<author>
<name sortKey="Ma, Xiao" sort="Ma, Xiao" uniqKey="Ma X" first="Xiao" last="Ma">Xiao Ma</name>
</author>
<author>
<name sortKey="Pan, Ji An" sort="Pan, Ji An" uniqKey="Pan J" first="Ji-An" last="Pan">Ji-An Pan</name>
</author>
<author>
<name sortKey="Guo, Deyin" sort="Guo, Deyin" uniqKey="Guo D" first="Deyin" last="Guo">Deyin Guo</name>
</author>
</analytic>
<series>
<title level="j">Virus research</title>
<idno type="eISSN">1872-7492</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Enzyme Inhibitors (metabolism)</term>
<term>Methyltransferases (antagonists & inhibitors)</term>
<term>Methyltransferases (metabolism)</term>
<term>Models, Molecular</term>
<term>Peptides (metabolism)</term>
<term>Protein Conformation</term>
<term>Protein Interaction Domains and Motifs</term>
<term>Protein Interaction Mapping</term>
<term>SARS Virus (enzymology)</term>
<term>Two-Hybrid System Techniques</term>
<term>Viral Nonstructural Proteins (antagonists & inhibitors)</term>
<term>Viral Nonstructural Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antienzymes (métabolisme)</term>
<term>Cartographie d'interactions entre protéines</term>
<term>Conformation des protéines</term>
<term>Methyltransferases (antagonistes et inhibiteurs)</term>
<term>Methyltransferases (métabolisme)</term>
<term>Modèles moléculaires</term>
<term>Motifs et domaines d'intéraction protéique</term>
<term>Peptides (métabolisme)</term>
<term>Protéines virales non structurales (antagonistes et inhibiteurs)</term>
<term>Protéines virales non structurales (métabolisme)</term>
<term>Techniques de double hybride</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Methyltransferases</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Enzyme Inhibitors</term>
<term>Methyltransferases</term>
<term>Peptides</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Methyltransferases</term>
<term>Protéines virales non structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Antienzymes</term>
<term>Methyltransferases</term>
<term>Peptides</term>
<term>Protéines virales non structurales</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Models, Molecular</term>
<term>Protein Conformation</term>
<term>Protein Interaction Domains and Motifs</term>
<term>Protein Interaction Mapping</term>
<term>Two-Hybrid System Techniques</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cartographie d'interactions entre protéines</term>
<term>Conformation des protéines</term>
<term>Modèles moléculaires</term>
<term>Motifs et domaines d'intéraction protéique</term>
<term>Techniques de double hybride</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Coronaviruses are the etiological agents of respiratory and enteric diseases in humans and livestock, exemplified by the life-threatening severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV). However, effective means for combating coronaviruses are still lacking. The interaction between nonstructural protein (nsp) 10 and nsp16 has been demonstrated and the crystal structure of SARS-CoV nsp16/10 complex has been revealed. As nsp10 acts as an essential trigger to activate the 2'-O-methyltransferase activity of nsp16, short peptides derived from nsp10 may have inhibitory effect on viral 2'-O-methyltransferase activity. In this study, we revealed that the domain of aa 65-107 of nsp10 was sufficient for its interaction with nsp16 and the region of aa 42-120 in nsp10, which is larger than the interaction domain, was needed for stimulating the nsp16 2'-O-methyltransferase activity. We further showed that two short peptides derived from the interaction domain of nsp10 could inhibit the 2'-O-methyltransferase activity of SARS-CoV nsp16/10 complex, thus providing a novel strategy and proof-of-principle study for developing peptide inhibitors against SARS-CoV.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">22659295</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>11</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-7492</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>167</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2012</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Virus research</Title>
<ISOAbbreviation>Virus Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.</ArticleTitle>
<Pagination>
<MedlinePgn>322-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2012.05.017</ELocationID>
<Abstract>
<AbstractText>Coronaviruses are the etiological agents of respiratory and enteric diseases in humans and livestock, exemplified by the life-threatening severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV). However, effective means for combating coronaviruses are still lacking. The interaction between nonstructural protein (nsp) 10 and nsp16 has been demonstrated and the crystal structure of SARS-CoV nsp16/10 complex has been revealed. As nsp10 acts as an essential trigger to activate the 2'-O-methyltransferase activity of nsp16, short peptides derived from nsp10 may have inhibitory effect on viral 2'-O-methyltransferase activity. In this study, we revealed that the domain of aa 65-107 of nsp10 was sufficient for its interaction with nsp16 and the region of aa 42-120 in nsp10, which is larger than the interaction domain, was needed for stimulating the nsp16 2'-O-methyltransferase activity. We further showed that two short peptides derived from the interaction domain of nsp10 could inhibit the 2'-O-methyltransferase activity of SARS-CoV nsp16/10 complex, thus providing a novel strategy and proof-of-principle study for developing peptide inhibitors against SARS-CoV.</AbstractText>
<CopyrightInformation>Copyright © 2012 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ke</LastName>
<ForeName>Min</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Yu</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Andong</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sun</LastName>
<ForeName>Ying</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Su</LastName>
<ForeName>Ceyang</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Hao</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jin</LastName>
<ForeName>Xu</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tao</LastName>
<ForeName>Jiali</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ma</LastName>
<ForeName>Xiao</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pan</LastName>
<ForeName>Ji-An</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Deyin</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>05</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Virus Res</MedlineTA>
<NlmUniqueID>8410979</NlmUniqueID>
<ISSNLinking>0168-1702</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558878">Nsp10 protein, SARS virus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.-</RegistryNumber>
<NameOfSubstance UI="D008780">Methyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.-</RegistryNumber>
<NameOfSubstance UI="C558879">Nsp16 protein, SARS virus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008780" MajorTopicYN="N">Methyltransferases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D025941" MajorTopicYN="Y">Protein Interaction Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020798" MajorTopicYN="N">Two-Hybrid System Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>04</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2012</Year>
<Month>05</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>05</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>6</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>6</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>11</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22659295</ArticleId>
<ArticleId IdType="pii">S0168-1702(12)00188-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.virusres.2012.05.017</ArticleId>
<ArticleId IdType="pmc">PMC7114426</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Mar 1;67(Pt 3):404-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21393853</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2008 May;133(2):136-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18255185</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12927536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Aug 6;320(4):1199-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15249217</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2005 Mar;5(3):147-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15766649</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Wiley Interdiscip Rev RNA. 2011 Mar-Apr;2(2):184-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21957005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2010 Nov 18;468(7322):452-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21085181</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cold Spring Harb Symp Quant Biol. 2001;66:301-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12762032</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1997 Jan;71(1):392-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8985362</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2011 Oct;7(10):e1002294</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22022266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2008 May 02;4(5):e1000054</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18451981</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2007 May 23;2(5):e459</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17520018</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biochem Mol Biol. 2007 Sep 30;40(5):649-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17927896</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Expert Opin Ther Pat. 2009 Apr;19(4):415-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19441924</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2008 Oct 01;3(10):e3299</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18827877</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2008 Oct;80(1):1-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18571739</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2011 Feb;12(2):137-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21217758</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Aug;80(16):7902-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16873247</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2010 Oct 22;285(43):33230-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20699222</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5108-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16549795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Aug;80(16):7894-901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16873246</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem Soc Trans. 2004 Dec;32(Pt 6):1081-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15506971</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2008 Aug;82(16):8071-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18417574</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3484-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19208801</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2011 May;7(5):e1002059</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21637813</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2010 Apr 22;6(4):e1000863</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20421945</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Expert Opin Ther Pat. 2009 Mar;19(3):357-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19449500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S21-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20801001</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001352 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001352 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22659295
   |texte=   Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22659295" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021